GSMCX
Price
$38.57
Change
-$0.30 (-0.77%)
Updated
Jul 30 closing price
Net Assets
1.11B
VMCIX
Price
$78.43
Change
-$0.35 (-0.44%)
Updated
Jul 30 closing price
Net Assets
192.45B
Interact to see
Advertisement

GSMCX vs VMCIX

Header iconGSMCX vs VMCIX Comparison
Open Charts GSMCX vs VMCIXBanner chart's image
Goldman Sachs Mid Cap Value Instl
Price$38.57
Change-$0.30 (-0.77%)
VolumeN/A
Net Assets1.11B
Vanguard Mid Cap Index Institutional
Price$78.43
Change-$0.35 (-0.44%)
VolumeN/A
Net Assets192.45B
GSMCX vs VMCIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSMCX vs. VMCIX commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSMCX is a Buy and VMCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCIX has more cash in the bank: 192B vs. GSMCX (1.11B). VMCIX pays higher dividends than GSMCX: VMCIX (1.53) vs GSMCX (0.99). GSMCX was incepted earlier than VMCIX: GSMCX (30 years) vs VMCIX (27 years). GSMCX (0.84) is less costly to investors than VMCIX (0.04). GSMCX is a more actively managed with annual turnover of: 56.00 vs. VMCIX (16.00). GSMCX has a lower initial minimum investment than VMCIX: GSMCX (1000000) vs VMCIX (5000000). VMCIX annual gain was more profitable for investors over the last year : 15.28 vs. GSMCX (4.45). VMCIX return over 5 years is better than : 66.79 vs. GSMCX (32.47).
GSMCXVMCIXGSMCX / VMCIX
Total Expense Ratio0.840.042,100%
Annual Report Gross Expense Ratio0.840.042,100%
Fund Existence30 years27 years-
Gain YTD6.3779.16770%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B192B1%
Annual Yield % from dividends0.991.5365%
Returns for 1 year4.4515.2829%
Returns for 3 years5.6134.2616%
Returns for 5 years32.4766.7949%
Returns for 10 years2.42128.242%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CATO2.980.09
+3.11%
CATO Corp
BCAX11.600.11
+0.96%
Bicara Therapeutics Inc.
LRN129.150.59
+0.46%
Stride
FDS409.16-6.33
-1.52%
Factset Research Systems
POAI0.78-0.02
-2.30%
Predictive Oncology